Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (251-260 of 574) with videos related to

Pageof 58
Sort By:
Chest|March 16, 2026
Integrating deep learning of low-dose computed tomography with clinical data for lung cancer risk predictionRenzo Phellan Aro, Stephen Lam, Matthew T Warkentin, et al.
Oral Oncology|April 20, 2025
Development of a patient reported outcomes based machine learning model to predict recurrences in head and neck cancerChristopher M K L Yao, Katrina Hueniken, Shao Hui Huang, et al.
Oral Oncology|January 8, 2013
Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patientsSteven Habbous, Karen P Chu, Luke T G Harland, et al.
Carcinogenesis|March 27, 2009
Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosisPenelope A Bradbury, Rihong Zhai, Jessica Hopkins, et al.
Lung Cancer (Amsterdam, Netherlands)|June 6, 2022
Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trialRoss A Soo, Eng Huat Tan, Hidetoshi Hayashi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymomaNajib Safieddine, Geoffrey Liu, Kris Cuningham, et al.
International Journal of Cancer|August 4, 2016
BRM polymorphisms, pancreatic cancer risk and survivalMaja Segedi, Laura N Anderson, Osvaldo Espin-Garcia, et al.
Molecular Cancer Research : MCR|March 19, 2015
CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell MigrationYuhong Wei, Ravi N Vellanki, Étienne Coyaud, et al.
Neoplasia (New York, N.Y.)|May 17, 2025
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus statusPardis Noormohammadpour, Katrina Hueniken, Martha Pienkowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2022
Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With <i>ALK</i>-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN StudyBenjamin J Solomon, Todd M Bauer, Sai-Hong Ignatius Ou, et al.
Pageof 58

Showing results (251-260 of 574) with videos related to

Sort By:
Pageof 58
Chest|March 16, 2026
Integrating deep learning of low-dose computed tomography with clinical data for lung cancer risk predictionRenzo Phellan Aro, Stephen Lam, Matthew T Warkentin, et al.
Oral Oncology|April 20, 2025
Development of a patient reported outcomes based machine learning model to predict recurrences in head and neck cancerChristopher M K L Yao, Katrina Hueniken, Shao Hui Huang, et al.
Oral Oncology|January 8, 2013
Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patientsSteven Habbous, Karen P Chu, Luke T G Harland, et al.
Carcinogenesis|March 27, 2009
Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosisPenelope A Bradbury, Rihong Zhai, Jessica Hopkins, et al.
Lung Cancer (Amsterdam, Netherlands)|June 6, 2022
Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trialRoss A Soo, Eng Huat Tan, Hidetoshi Hayashi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymomaNajib Safieddine, Geoffrey Liu, Kris Cuningham, et al.
International Journal of Cancer|August 4, 2016
BRM polymorphisms, pancreatic cancer risk and survivalMaja Segedi, Laura N Anderson, Osvaldo Espin-Garcia, et al.
Molecular Cancer Research : MCR|March 19, 2015
CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell MigrationYuhong Wei, Ravi N Vellanki, Étienne Coyaud, et al.
Neoplasia (New York, N.Y.)|May 17, 2025
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus statusPardis Noormohammadpour, Katrina Hueniken, Martha Pienkowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2022
Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With <i>ALK</i>-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN StudyBenjamin J Solomon, Todd M Bauer, Sai-Hong Ignatius Ou, et al.
Pageof 58